The high transmission rate and fast mutation capacity of SARS-CoV-2 requires development of low-cost/widely deployable biosensor technologies. Here, we describe the development of an enzymatic biosensor to monitor SARS-CoV-2 and its emerging variants in human saliva based. Biotinylated angiotensin converting enzyme (ACE2) was immobilized on streptavidin-coated fiber optic probes and gold chips for biolayer interferometry (BLI) and surface plasmon resonance (SPR), respectively. Kinetics of ACE2-virion binding for wild-type, Delta, UK, and South Africa variants were analyzed and compared for informing the development of a mobile detection system.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.